<DOC>
	<DOC>NCT00724477</DOC>
	<brief_summary>The main objective of this study is to determine the percentage of patients who met the low-density lipoprotein cholesterol (LDL-C) objective with INEGY, that were not under statin monotherapy treatment.</brief_summary>
	<brief_title>Retrospective Evaluation of the Percentage of Subjects Who Have Reached Their LDL-C Objectives After Treatment With INEGY (Study P05103)(COMPLETED)</brief_title>
	<detailed_description>The type of patient sampling used was consecutive patient sampling</detailed_description>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Ezetimibe, Simvastatin Drug Combination</mesh_term>
	<criteria>man or woman aged over 18; patient suffering from primary hypercholesterolemia; patient justifying treatment with INEGY® (2nd intention); patient currently treated with INEGY® for at least 4 weeks; patient with a lipid profile before treatment with INEGY®, documenting a level of LDLC exceeding the therapeutic objective under treatment with a statin as monotherapy; patient with an evaluation of lipid disorder (EAL) treated with INEGY®, performed within 1 to 3 months of starting treatment. patient not previously treated with a statin; patient previously treated with a combination of hypolipemics; patient treated with INEGY® as first intention; patient treated with INEGY® for less than 4 weeks; patient already included in this study.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>